These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 24125106

  • 21. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.
    O'Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, Webb J, Kulkarni M, Dawson D, Sulaibeekh L, Chandrasekaran B, Bucciarelli-Ducci C, Pasquale F, Cowie MR, McKenna WJ, Sheppard MN, Elliott PM, Pennell DJ, Prasad SK.
    J Am Coll Cardiol; 2010 Sep 07; 56(11):867-74. PubMed ID: 20688032
    [Abstract] [Full Text] [Related]

  • 22. Type of desmin expression in cardiomyocytes - a good marker of heart failure development in idiopathic dilated cardiomyopathy.
    Pawlak A, Gil RJ, Kulawik T, Pronicki M, Karkucińska-Więckowska A, Szymańska-Dębińska T, Gil K, Lagwinski N, Czarnowska E.
    J Intern Med; 2012 Sep 07; 272(3):287-97. PubMed ID: 22292457
    [Abstract] [Full Text] [Related]

  • 23. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging.
    Chalil S, Stegemann B, Muhyaldeen S, Khadjooi K, Smith RE, Jordan PJ, Leyva F.
    J Am Coll Cardiol; 2007 Jul 17; 50(3):243-52. PubMed ID: 17631217
    [Abstract] [Full Text] [Related]

  • 24. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery.
    Grün S, Schumm J, Greulich S, Wagner A, Schneider S, Bruder O, Kispert EM, Hill S, Ong P, Klingel K, Kandolf R, Sechtem U, Mahrholdt H.
    J Am Coll Cardiol; 2012 May 01; 59(18):1604-15. PubMed ID: 22365425
    [Abstract] [Full Text] [Related]

  • 25. Relationship between morphologic features of myocardial tissue and left ventricular function in patients with aortic valve disease and left ventricular hypertrophy.
    Chang HW, Kim KH, Kim JS, Kim KH, Kim YJ.
    J Heart Valve Dis; 2013 Jul 01; 22(4):476-83. PubMed ID: 24224409
    [Abstract] [Full Text] [Related]

  • 26. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T, von Haehling S, Peter T, Allhoff T, Cicoira M, Doehner W, Ponikowski P, Filippatos GS, Rozentryt P, Drexler H, Anker SD, Wollert KC.
    J Am Coll Cardiol; 2007 Sep 11; 50(11):1054-60. PubMed ID: 17825714
    [Abstract] [Full Text] [Related]

  • 27. Predictors of mortality and hospitalization for cardiac causes in patients with heart failure and nonischemic heart disease: a subanalysis of the ALPHA study.
    Anselmino M, De Ferrari GM, Massa R, Manca L, Tritto M, Molon G, Curnis A, Devecchi P, Sarzi Braga S, Bartesaghi G, Klersy C, Accardi F, Salerno-Uriarte JA, ALPHA Study Group Investigators.
    Pacing Clin Electrophysiol; 2009 Mar 11; 32 Suppl 1():S214-8. PubMed ID: 19250099
    [Abstract] [Full Text] [Related]

  • 28. Additive prognostic value of subjective assessment with respect to clinical cardiological data in patients with chronic heart failure.
    Majani G, Pierobon A, Pinna GD, Giardini A, Maestri R, La Rovere MT.
    Eur J Cardiovasc Prev Rehabil; 2011 Dec 11; 18(6):836-42. PubMed ID: 21450593
    [Abstract] [Full Text] [Related]

  • 29. Impact of gender on outcomes in chronic systolic heart failure.
    Ng AC, Wong HS, Yong AS, Sindone AP.
    Int J Cardiol; 2007 Apr 25; 117(2):214-21. PubMed ID: 17064798
    [Abstract] [Full Text] [Related]

  • 30. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension.
    van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, Ijsselmuiden AJ, Schalkwijk CG, Bronzwaer JG, Diamant M, Borbély A, van der Velden J, Stienen GJ, Laarman GJ, Niessen HW, Paulus WJ.
    Circulation; 2008 Jan 01; 117(1):43-51. PubMed ID: 18071071
    [Abstract] [Full Text] [Related]

  • 31. Prognostic value of cystatin C on admission in heart failure with preserved ejection fraction.
    Carrasco-Sánchez FJ, Galisteo-Almeda L, Páez-Rubio I, Martínez-Marcos FJ, Camacho-Vázquez C, Ruiz-Frutos C, Pujol-De La Llave E.
    J Card Fail; 2011 Jan 01; 17(1):31-8. PubMed ID: 21187262
    [Abstract] [Full Text] [Related]

  • 32. COPD predicts mortality in HF: the Norwegian Heart Failure Registry.
    De Blois J, Simard S, Atar D, Agewall S, Norwegian Heart Failure Registry.
    J Card Fail; 2010 Mar 01; 16(3):225-9. PubMed ID: 20206897
    [Abstract] [Full Text] [Related]

  • 33. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R.
    J Am Coll Cardiol; 2008 Jul 22; 52(4):266-72. PubMed ID: 18634981
    [Abstract] [Full Text] [Related]

  • 34. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C, Leowattana W, Sukumalchantra Y, Chaisupamonkollarp S, Watanawaroon S, Chivatanaporn B, Bhuripanyo K, Mahanonda N.
    J Med Assoc Thai; 2003 May 22; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [Abstract] [Full Text] [Related]

  • 35. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG, Schuurman R, Andrea B, Ripoli A, Coceani M, Chiappino S, Todiere G, Srebot V, Passino C, Aquaro GD, Emdin M, Lombardi M.
    Circ Cardiovasc Imaging; 2013 Sep 22; 6(5):790-9. PubMed ID: 23934992
    [Abstract] [Full Text] [Related]

  • 36. Changes in B-type natriuretic peptides after surgical ventricular restoration.
    Sartipy U, Albåge A, Larsson PT, Insulander P, Lindblom D.
    Eur J Cardiothorac Surg; 2007 May 22; 31(5):922-8. PubMed ID: 17321144
    [Abstract] [Full Text] [Related]

  • 37. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C, Ometto R, Pasinato S, Finocchi G, La Vecchia L, Fontanelli A.
    Ital Heart J; 2004 May 22; 5(5):364-70. PubMed ID: 15185900
    [Abstract] [Full Text] [Related]

  • 38. Expression of Osteopontin and Gremlin 1 Proteins in Cardiomyocytes in Ischemic Heart Failure.
    Kuprytė M, Lesauskaitė V, Siratavičiūtė V, Utkienė L, Jusienė L, Pangonytė D.
    Int J Mol Sci; 2024 Jul 28; 25(15):. PubMed ID: 39125809
    [Abstract] [Full Text] [Related]

  • 39. Circulating collagen metabolites, myocardial fibrosis and heart failure in aortic valve stenosis.
    Kupari M, Laine M, Turto H, Lommi J, Werkkala K.
    J Heart Valve Dis; 2013 Mar 28; 22(2):166-76. PubMed ID: 23798204
    [Abstract] [Full Text] [Related]

  • 40. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients.
    Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA, Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators.
    Circulation; 2005 Dec 13; 112(24):3738-44. PubMed ID: 16330684
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.